Abarceo Pharma
  • About
  • Team
    • Management
    • Board
    • Scientific Advisors
  • Pipeline
  • News
  • Contact
Select Page
Abarceo attended the Almi Invest Rooftop Mingle on May 7

Abarceo attended the Almi Invest Rooftop Mingle on May 7

by SD-AbarceoPharma | May 15, 2026 | Events, Investors

Abarceo’s CEO Adam Bruce participated at the Almi Invest Rooftop Mingle on May 7th and gave an inspiring presentation. “I’m grateful for the opportunity to take part in this important event,” says Adam Bruce.          ...

Recent Posts

  • Abarceo attended the Almi Invest Rooftop Mingle on May 7
  • Redeye Theme Event Diabetes 2026
  • RESI Europe 2026
  • Abarceo attended ATTD
  • World Diabetes Day

Recent Comments

    Abarceo Pharma AB

    Medeon Science Park
    Per Albin Hanssons vä 41, 205 12
    Malmö, Sweden

    Email: info@abarceo.com

    Abarceo Pharma is a Lund University Holding company and was founded in December 2017 by Scientific founders Prof. Claes Wollheim, MD, and Associate Prof. Albert Salehi. The company is dedicated to developing novel therapeutics for type-2 diabetes based upon a deep molecular and genetic understanding of the disease.

    ©Copyright 2018 – 2026 | All Rights Reserved | Reg. No. 559139-7160 | Privacy Policy